30 Oct 2024 16:06 CET

Issuer

AKER BIOMARINE ASA

Aker BioMarine will release the third quarter 2024 results on Friday 1 November
2024 at 07:00 CET. At 09:00 CET on the same day, the management will host a
webcast to present the results.

The webcasted presentation will be in English. To join, please use the link that
will be available at www.akerbiomarine.com/investor.

A replay of the presentation will be made available soon after the presentation
at the same web page.

For further information, please contact
Christopher Robin Vinter, VP Strategic Finance & IR
Mobile: +47 911 60 820
Email: christopher.vinter@akerbiomarine.com


About Aker BioMarine
Aker BioMarine is a leading human health and nutrition innovator that develops
krill-derived products for consumer health and nutrition. Krill is a natural,
powerful, and health-promoting source of nutrients from the pristine waters of
Antarctica, and Aker BioMarine has a unique position in its industry. The
ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and
PL+, as well as the consumer brand, Kori Krill. The innovative approach also
extends into the spin-offs AION (reduce and recycle plastic waste across
industries) and Understory (a protein brand). Aker BioMarine is listed on the
Oslo Stock Exchange (AKBM). More information is available at
www.akerbiomarine.com.


Source

Aker BioMarine ASA

Provider

Oslo Børs Newspoint

Company Name

AKER BIOMARINE ASA

ISIN

NO0010886625

Symbol

AKBM

Market

Oslo Børs